Clinical Outcome of Patients with Oropharyngeal Carcinoma

Abstract

The level of incidence of patients with oropharyngeal cancers increased from 1998 to 2010. The purpose of the present study was to investigate therapeutic strategies for oropharyngeal cancers based on an examination of clinical outcomes in our department. The study subjects comprised 69 patients with oropharyngeal cancers treated in our hospital from January 2007 to December 2011. Overall survival was examined with the Kaplan-Meier survival curve. Subsite, stage, treatment (surgery group vs radiation and chemotherapy group) and prognosis were reviewed retrospectively. Overall survival was 59.9%. The overall survival was not associated with any difference in the tumor size (T1 and T2 vs T3 and T4), lymph node status (N0 vs N+), stage (I, II and III vs IV), subsite, or treatment. As for the treatment, overall survival of the surgery group was 62.1%, while that of the radiation and chemotherapy group was 76.8%.